Researcher.Life Logo

Bioanalysis : Impact Factor & More

eISSN: 1757-6199pISSN: 1757-6180

Key Metrics

CiteScore
3.5
H-Index
67
Impact Factor
< 5
SJR
Q2Analytical Chemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Bioanalysis

Bioanalysis Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher NEWLANDS PRESS LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Bioanalysis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bioanalysis

Comparison of 2D-LC and LC-MS/MS self- calibration internal standard method for the determination of quetiapine in serum.
  • 14 May 2026
  • Bioanalysis
A dual-stage stabilized LC-MS/MS method for the quantification of ibuprofenamine in human plasma.
  • 12 May 2026
  • Bioanalysis
Fluorescent carbon dots for therapeutic drug monitoring: advances in sensing methotrexate and 6-mercaptopurine.
  • 7 May 2026
  • Bioanalysis
Rethinking immunogenicity: an integrated approach reveals the PK/PD impact of pre-existing and drug-sustaining ADA.
  • 5 May 2026
  • Bioanalysis
Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programs.
  • 30 Apr 2026
  • Bioanalysis
Comparative assessment of RT-dPCR and RT-qPCR for RNA quantification in IgG mRNA-lipid nanoparticle bioanalysis.
  • 30 Apr 2026
  • Bioanalysis
Comparison of 2D-LC and LC-MS/MS self- calibration internal standard method for the determination of quetiapine in serum.
  • 14 May 2026
  • Bioanalysis
A dual-stage stabilized LC-MS/MS method for the quantification of ibuprofenamine in human plasma.
  • 12 May 2026
  • Bioanalysis
Fluorescent carbon dots for therapeutic drug monitoring: advances in sensing methotrexate and 6-mercaptopurine.
  • 7 May 2026
  • Bioanalysis
Rethinking immunogenicity: an integrated approach reveals the PK/PD impact of pre-existing and drug-sustaining ADA.
  • 5 May 2026
  • Bioanalysis
Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programs.
  • 30 Apr 2026
  • Bioanalysis
Comparative assessment of RT-dPCR and RT-qPCR for RNA quantification in IgG mRNA-lipid nanoparticle bioanalysis.
  • 30 Apr 2026
  • Bioanalysis

FAQs on Bioanalysis